Burkhart Erin

Track

Insider profile

Burkhart Erin's trades of Biomarin Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
168.54
Quantity 41,361
Value US$1,260,006
Transaction date
Proposed sale
Price
71.52
Quantity 1,295
Value US$92,618
Transaction date
Proposed sale
Price
68.38
Quantity 1,344
Value US$91,903
Transaction date
Proposed sale
Price
90.00
Quantity 2,286
Value US$205,740
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-20 2025-05-20
PrS Proposed sale
41,361
168.54
US$1,260,006 		41,361 168.54 US$1,260,006
2025-05-20 2025-05-20
PlS Planned sale
78,598 -20.0%
75.62
US$381,875 		78,598 -20.0% 75.62 US$381,875
2025-03-20 2025-03-19
PlS Planned sale
37,667 +18.2%
403.46
US$3,743,055 		37,667 +18.2% 403.46 US$3,743,055
2025-03-19 2025-03-19
PrS Proposed sale
1,295
71.52
US$92,618 		1,295 71.52 US$92,618
2025-02-25 2025-02-24
PlS Planned sale
1,344 -9.3%
68.38
US$91,903 		1,344 -9.3% 68.38 US$91,903
2025-02-24 2025-02-24
PrS Proposed sale
1,344
68.38
US$91,903 		1,344 68.38 US$91,903
2024-08-15 2024-08-13
PlS Planned sale
714 -4.7%
90.00
US$64,260 		714 -4.7% 90.00 US$64,260
2024-08-13 2024-08-13
PrS Proposed sale
714
90.00
US$64,260 		714 90.00 US$64,260
2024-04-12 2024-04-10
PlS Planned sale
2,286 -12.4%
90.00
US$205,740 		2,286 -12.4% 90.00 US$205,740
2024-04-10 2024-04-10
PrS Proposed sale
2,286
90.00
US$205,740 		2,286 90.00 US$205,740